Category: Side Effect: Cardiovascular (heart attack, stroke, heart failure, PE, DVT)
-
Lancet Article About Avandia Study Omits Key Fact Says Nissen And Other Critics
Whether Avandia Causes Heart Attacks Remains An Open Issue, Despite Recent RECORD Study Results (Posted by Tom Lamb at DrugInjuryWatch.com) On June 5, 2009, at the annual meeting of the American Diabetes Association (ADA) in…
-
Birth Control Pill YAZ Is Subject Of Ongoing Safety Study Regarding Cardiovascular Side Effects
A Comparison Of This "Fourth Generation" DRSP / EE Pill To Other Established Oral Contraceptives For Incidence Of Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Heart Attack (MI), And Stroke (CVA) (Posted by Tom Lamb at…
-
Hydroxycut Weight-Loss Products Are Recalled Due To Cases Of Serious Liver Injury
Reports Made To The FDA Have Involved Hepatitis, Liver Failure, Liver Transplant, And Death (Posted by Tom Lamb at DrugInjuryWatch.com) On May 1, 2009 the FDA warned people to stop using Hydroxycut products – made…
-
Caraco Digoxin Recall Issued March 31, 2009 Is Due To Pill-Size Problems
Digitek Brand Of Generic Digoxin Tablets Had Been Recalled In April 2008 For Same Reason (Posted by Tom Lamb at DrugInjuryWatch.com) On March 31, 2009 the FDA announced another generic digoxin pill recall by…
-
Watson Pharmaceuticals Recalls One Lot Of Generic Propafenone Pills Due To Possible Manufacturing Problem
At Present, This March 2009 Recall Is Limited To Propafenone HCL 225 mg Tablets Shipped Between October 15, 2008 And November 26, 2008 (Posted by Tom Lamb at DrugInjuryWatch.com) By means of a MedWatch…
-
Avandia And Actos Are In Same Class, But One Of These Diabetes Drugs Has More Safety Risks
New Study Shows Older Diabetics Were More Likely To Develop Heart Failure Or Die When Using Avandia As Opposed To Actos (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________ UPDATE: Avandia Should Be Removed from…
-
Internal Glaxo Emails Show Drug Company Was Concerned In 2007 About Avandia’s Heart Attack Risks
Senator Grassley's Report On How Glaxo Defended Avandia In Wake Of 2007 NEJM Article By Nissen And Wolski Is Expected To Be Released Soon (Posted by Tom Lamb at DrugInjuryWatch.com) On May 21, 2007,…
-
Sprint Fidelis Lead Wire Failures May Be On The Rise According To February 2009 Journal Article By Hauser And Hayes
Physicians Must Consider The Pros And Cons Of Surgical Removal Before Heart Device Shocks Unnecessarily Or Fails To Work When Patient Needed Shock (Posted by Tom Lamb at DrugInjuryWatch.com) On February 23, 2009 the…
-
Risk Of Digoxin Toxicity / Digitalis Poisoning Higher In First Two Months Following A Hospitalization
Researchers Looked For Possible Digoxin-Related Adverse Drug Events In Older Patients From Pennsylvania (Posted by Tom Lamb at DrugInjuryWatch.com) In the wake of the generic digoxin pill Digitek being recalled in the spring of…
-
When Will FDA Report Its Findings About Any Link Between Fosamax And Atrial Fibrillation
In October 2007 The Agency Estimated It Would Need Up To 12 Months To Complete Investigation Regarding This Possible Bisphosphonate Side Effect (Posted by Tom Lamb at DrugInjuryWatch.com) The possible link between bisphosphonates such as Fosamax…